BG63012B1 - 5,6-дихидропиронови производни като протеазни инхибитори и антивирусни средства - Google Patents

5,6-дихидропиронови производни като протеазни инхибитори и антивирусни средства Download PDF

Info

Publication number
BG63012B1
BG63012B1 BG100563A BG10056396A BG63012B1 BG 63012 B1 BG63012 B1 BG 63012B1 BG 100563 A BG100563 A BG 100563A BG 10056396 A BG10056396 A BG 10056396A BG 63012 B1 BG63012 B1 BG 63012B1
Authority
BG
Bulgaria
Prior art keywords
dihydro
pyran
hydroxy
phenyl
thio
Prior art date
Application number
BG100563A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100563A (bg
Inventor
Edmund Ellsworth
Elizabeth Lunney
Bradley Tait
Original Assignee
Parke, Davis & Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,821 external-priority patent/US5789440A/en
Application filed by Parke, Davis & Company filed Critical Parke, Davis & Company
Publication of BG100563A publication Critical patent/BG100563A/bg
Publication of BG63012B1 publication Critical patent/BG63012B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/26Thiols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG100563A 1993-11-19 1996-05-03 5,6-дихидропиронови производни като протеазни инхибитори и антивирусни средства BG63012B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15544393A 1993-11-19 1993-11-19
US08/319,821 US5789440A (en) 1993-11-19 1994-10-12 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
PCT/US1994/012234 WO1995014011A2 (en) 1993-11-19 1994-10-26 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (2)

Publication Number Publication Date
BG100563A BG100563A (bg) 1996-12-31
BG63012B1 true BG63012B1 (bg) 2001-01-31

Family

ID=26852339

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100563A BG63012B1 (bg) 1993-11-19 1996-05-03 5,6-дихидропиронови производни като протеазни инхибитори и антивирусни средства

Country Status (27)

Country Link
US (1) US5936128A (et)
EP (1) EP0729463B1 (et)
JP (1) JP3698435B2 (et)
AT (1) ATE217871T1 (et)
AU (1) AU680064B2 (et)
BG (1) BG63012B1 (et)
CA (1) CA2176041A1 (et)
CZ (1) CZ291856B6 (et)
DE (1) DE69430671T2 (et)
DK (1) DK0729463T3 (et)
EE (1) EE9600045A (et)
ES (1) ES2176263T3 (et)
FI (1) FI962021A (et)
HR (1) HRP940936B1 (et)
HU (1) HUT75225A (et)
IL (1) IL111673A (et)
MD (2) MD1560G2 (et)
NO (1) NO315117B1 (et)
NZ (1) NZ275318A (et)
PL (1) PL180634B1 (et)
PT (1) PT729463E (et)
RO (1) RO117850B1 (et)
RU (1) RU2160733C2 (et)
SI (1) SI0729463T1 (et)
SK (1) SK283240B6 (et)
TJ (1) TJ320B (et)
WO (1) WO1995014011A2 (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014812A2 (en) * 1995-10-16 1997-04-24 Chiron Corporation Method of screening for factors that modulate gene expression
CA2235394A1 (en) 1995-11-13 1997-05-22 Gerard Voerman Anti-viral isolates obtainable from leeches
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
US6087455A (en) * 1997-12-19 2000-07-11 Shell Oil Company Process for hydrogenation of macromolecular organic substrates
NZ510013A (en) 1998-09-11 2003-11-28 Warner Lambert Co Dihydropyrones with selected heterocycles replacing the phenyls bearing polar substituents used as HIV protease inhibitors
DE10030094A1 (de) 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
DE10100175A1 (de) * 2001-01-04 2002-07-11 Bayer Ag Hetarylsubstituierte Homotetram-und Homotetronsäuren
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
GEP20094751B (en) 2004-08-18 2009-08-10 Pfizer Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
WO2009126305A1 (en) * 2008-04-11 2009-10-15 The Trustees Of Columbia University Glucose metabolism modulating compounds
US10624943B2 (en) 2013-11-11 2020-04-21 Kuality Herbceutics, LLC Kava derived therapeutic compounds and methods of use thereof
CN108026084A (zh) * 2015-05-07 2018-05-11 夸利蒂赫布丘蒂克斯公司 治疗化合物及其使用方法
US10889565B2 (en) * 2016-06-14 2021-01-12 Bristol-Myers Squibb Company 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
AU2017347549A1 (en) 2016-10-17 2019-05-02 Genentech, Inc. Therapeutic compounds and methods of use thereof
GB201707856D0 (en) 2017-05-16 2017-06-28 Arctic Pharma As Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3206276A (en) * 1961-09-28 1965-09-14 Minerals Engineering Company Process for recovery of pure v2o5 from vanadium bearing materials
US3206476A (en) * 1962-06-04 1965-09-14 Sterling Drug Inc 3-substituted-4-hydroxy-6-aryl-2-pyrones and preparation
US3931235A (en) * 1972-12-18 1976-01-06 The Dow Chemical Company Process for preparing sulfur-containing hydroxy pyrones
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
IL85347A0 (en) * 1987-02-11 1988-07-31 May & Baker Ltd Cyclic diones
EP0403535A1 (en) * 1988-03-01 1990-12-27 The Upjohn Company Coumarins to inhibit reverse transcriptase in humans
JPH03227923A (ja) * 1990-01-30 1991-10-08 Sawai Seiyaku Kk ひと免疫不全ウイルス疾患処置剤
WO1993010645A1 (en) * 1991-11-18 1993-05-27 Motorola, Inc. User selectable noise canceling for portable microphones
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses

Also Published As

Publication number Publication date
IL111673A0 (en) 1995-01-24
HRP940936A2 (en) 1997-08-31
NO962018L (no) 1996-07-04
EE9600045A (et) 1996-10-15
DE69430671D1 (de) 2002-06-27
ES2176263T3 (es) 2002-12-01
MD1560F2 (en) 2000-11-30
HUT75225A (en) 1997-04-28
HRP940936B1 (en) 2003-12-31
PL314483A1 (en) 1996-09-16
US5936128A (en) 1999-08-10
MD1560G2 (ro) 2001-07-31
NO962018D0 (no) 1996-05-15
EP0729463B1 (en) 2002-05-22
TJ320B (en) 2001-10-22
WO1995014011A3 (en) 1995-06-29
SK64696A3 (en) 1997-03-05
CA2176041A1 (en) 1995-05-26
BG100563A (bg) 1996-12-31
JPH09505292A (ja) 1997-05-27
PL180634B1 (pl) 2001-03-30
JP3698435B2 (ja) 2005-09-21
EP0729463A1 (en) 1996-09-04
RO117850B1 (ro) 2002-08-30
FI962021A0 (fi) 1996-05-13
SK283240B6 (sk) 2003-04-01
WO1995014011A2 (en) 1995-05-26
PT729463E (pt) 2002-10-31
SI0729463T1 (en) 2002-08-31
HU9601349D0 (en) 1996-07-29
DE69430671T2 (de) 2002-11-21
AU680064B2 (en) 1997-07-17
RU2160733C2 (ru) 2000-12-20
NZ275318A (en) 1999-06-29
CZ136896A3 (en) 1997-12-17
AU8090094A (en) 1995-06-06
DK0729463T3 (da) 2002-09-09
MD960172A (en) 1999-01-31
NO315117B1 (no) 2003-07-14
IL111673A (en) 1999-04-11
FI962021A (fi) 1996-07-12
ATE217871T1 (de) 2002-06-15
CZ291856B6 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
JP3684426B2 (ja) プロテアーゼ阻害剤および抗ウイルス剤としての5,6−ジヒドロピロン誘導体
BG63012B1 (bg) 5,6-дихидропиронови производни като протеазни инхибитори и антивирусни средства
US5840751A (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
RU2136674C1 (ru) Производные пирона, фармацевтическая композиция с антибактериальной и антивирусной активностью, способ лечения вызванных ретровирусом инфекции или заболевания
SK63996A3 (en) Pyrone derivatives as protease inhibitors and antiviral agents
KR100441361B1 (ko) 프로테아제억제제및항바이러스제로서의5,6-디히드로피론유도체
KR100447557B1 (ko) 프로테아제억제제및항바이러스제로서의5,6-디히드로피론유도체
HUT77719A (hu) Proteáz enzimeket gátló pironszármazékok és azokat hatóanyagként tartalmazó vírusellenes gyógyászati készítmények